{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "Development of acute lymphoblastic leukemia following hemophagocytic lymphohistiocytosis : is it secondary leukemia?",
    "dc:creator": [
        "SUZUKI, T",
        "MUGISHIMA, H",
        "YAMADA, A",
        "NAGATA, T",
        "SHICHINO, H",
        "CHIN, M",
        "IMASHUKU, S",
        "HARADA, K"
    ],
    "dc:relation": "International journal of hematology -- Int. j. hematol, ISSN 0925-5710, Vol. 70 (1) , pp. 58-59",
    "dc:date": "1999",
    "dc:type": [
        "Text",
        "Article"
    ],
    "dc:language": "English",
    "dc:publisher": "Springer",
    "dc:format": [
        "print",
        "10 ref"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Enzyme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Histiocytose"
        },
        {
            "@xml:lang": "fr",
            "#text": "Homme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Hémopathie maligne"
        },
        {
            "@xml:lang": "fr",
            "#text": "Hémopathie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Isomerases"
        },
        {
            "@xml:lang": "fr",
            "#text": "Lymphoprolifératif syndrome"
        },
        {
            "@xml:lang": "fr",
            "#text": "Aigu"
        },
        {
            "@xml:lang": "fr",
            "#text": "Anticancéreux"
        },
        {
            "@xml:lang": "fr",
            "#text": "Antimitotique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Association médicamenteuse"
        },
        {
            "@xml:lang": "fr",
            "#text": "Chimiothérapie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Corticostéroïde"
        },
        {
            "@xml:lang": "fr",
            "#text": "DNA topoisomerase (ATP-hydrolysing)"
        },
        {
            "@xml:lang": "fr",
            "#text": "Dexaméthasone"
        },
        {
            "@xml:lang": "fr",
            "#text": "Enfant"
        },
        {
            "@xml:lang": "fr",
            "#text": "Etoposide"
        },
        {
            "@xml:lang": "fr",
            "#text": "Etude cas"
        },
        {
            "@xml:lang": "fr",
            "#text": "Femelle"
        },
        {
            "@xml:lang": "fr",
            "#text": "Glucocorticoïde"
        },
        {
            "@xml:lang": "fr",
            "#text": "Hémophagocytose syndrome"
        },
        {
            "@xml:lang": "fr",
            "#text": "Inhibiteur enzyme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Leucémie lymphoblastique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Lymphohistiocytose hémophagocytique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Podophyllotoxine dérivé"
        },
        {
            "@xml:lang": "fr",
            "#text": "Second cancer"
        },
        {
            "@xml:lang": "fr",
            "#text": "Traitement"
        },
        {
            "@xml:lang": "en",
            "#text": "Enzyme"
        },
        {
            "@xml:lang": "en",
            "#text": "Histiocytosis"
        },
        {
            "@xml:lang": "en",
            "#text": "Human"
        },
        {
            "@xml:lang": "en",
            "#text": "Malignant hemopathy"
        },
        {
            "@xml:lang": "en",
            "#text": "Hemopathy"
        },
        {
            "@xml:lang": "en",
            "#text": "Isomerases"
        },
        {
            "@xml:lang": "en",
            "#text": "Lymphoproliferative syndrome"
        },
        {
            "@xml:lang": "en",
            "#text": "Acute"
        },
        {
            "@xml:lang": "en",
            "#text": "Antineoplastic agent"
        },
        {
            "@xml:lang": "en",
            "#text": "Antimitotic"
        },
        {
            "@xml:lang": "en",
            "#text": "Drug combination"
        },
        {
            "@xml:lang": "en",
            "#text": "Chemotherapy"
        },
        {
            "@xml:lang": "en",
            "#text": "Corticosteroid"
        },
        {
            "@xml:lang": "en",
            "#text": "DNA topoisomerase (ATP-hydrolysing)"
        },
        {
            "@xml:lang": "en",
            "#text": "Dexamethasone"
        },
        {
            "@xml:lang": "en",
            "#text": "Child"
        },
        {
            "@xml:lang": "en",
            "#text": "Etoposide"
        },
        {
            "@xml:lang": "en",
            "#text": "Case study"
        },
        {
            "@xml:lang": "en",
            "#text": "Female"
        },
        {
            "@xml:lang": "en",
            "#text": "Glucocorticoid"
        },
        {
            "@xml:lang": "en",
            "#text": "Hemophagocytic syndrome"
        },
        {
            "@xml:lang": "en",
            "#text": "Enzyme inhibitor"
        },
        {
            "@xml:lang": "en",
            "#text": "Acute lymphocytic leukemia"
        },
        {
            "@xml:lang": "en",
            "#text": "Hemophagocytic lymphohistiocytosis"
        },
        {
            "@xml:lang": "en",
            "#text": "Podophyllotoxine derivatives"
        },
        {
            "@xml:lang": "en",
            "#text": "Second cancer"
        },
        {
            "@xml:lang": "en",
            "#text": "Treatment"
        },
        {
            "@xml:lang": "es",
            "#text": "Enzima"
        },
        {
            "@xml:lang": "es",
            "#text": "Histiocitosis"
        },
        {
            "@xml:lang": "es",
            "#text": "Hombre"
        },
        {
            "@xml:lang": "es",
            "#text": "Hemopatía maligna"
        },
        {
            "@xml:lang": "es",
            "#text": "Hemopatía"
        },
        {
            "@xml:lang": "es",
            "#text": "Isomerases"
        },
        {
            "@xml:lang": "es",
            "#text": "Linfoproliferativo síndrome"
        },
        {
            "@xml:lang": "es",
            "#text": "Agudo"
        },
        {
            "@xml:lang": "es",
            "#text": "Anticanceroso"
        },
        {
            "@xml:lang": "es",
            "#text": "Antimitótico"
        },
        {
            "@xml:lang": "es",
            "#text": "Asociación medicamentosa"
        },
        {
            "@xml:lang": "es",
            "#text": "Quimioterapia"
        },
        {
            "@xml:lang": "es",
            "#text": "Corticoesteroide"
        },
        {
            "@xml:lang": "es",
            "#text": "DNA topoisomerase (ATP-hydrolysing)"
        },
        {
            "@xml:lang": "es",
            "#text": "Dexametasona"
        },
        {
            "@xml:lang": "es",
            "#text": "Niño"
        },
        {
            "@xml:lang": "es",
            "#text": "Etopósido"
        },
        {
            "@xml:lang": "es",
            "#text": "Estudio caso"
        },
        {
            "@xml:lang": "es",
            "#text": "Hembra"
        },
        {
            "@xml:lang": "es",
            "#text": "Glucocorticoide"
        },
        {
            "@xml:lang": "es",
            "#text": "Hemofagocitosis síndrome"
        },
        {
            "@xml:lang": "es",
            "#text": "Inhibidor enzima"
        },
        {
            "@xml:lang": "es",
            "#text": "Leucemia linfoblástica"
        },
        {
            "@xml:lang": "es",
            "#text": "Linfohistiocitosis hemofagocitica"
        },
        {
            "@xml:lang": "es",
            "#text": "Podofilotoxina derivado"
        },
        {
            "@xml:lang": "es",
            "#text": "Segundo cáncer"
        },
        {
            "@xml:lang": "es",
            "#text": "Tratamiento"
        },
        "002B19B: Leucémies. Lymphomes malins. Réticuloses malignes. Hématodermies. Splénomégalie myéloïde / Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 1284437"
}